Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Biotechnol. 2014 Aug;32(8):724-6. doi: 10.1038/nbt.2973.

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.

Author information

1
1] Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield Western Bank, Sheffield, UK. [2] Coordinator of the International Stem Cell Initiative.
2
Access BIO, Boyce, Virginia, USA.
3
Alliance for Regenerative Medicine/Athersys, Cleveland, Ohio, USA.
4
California Institute for Regenerative Medicine, San Francisco, California, USA.
5
International Society for Cell Therapy, Vancouver, BC, Canada.
6
American Society of Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada.
7
1] National Institutes of Health Center for Regenerative Medicine, Bethesda, Maryland, USA. [2] New York Stem Cell Foundation, New York, New York, USA.
8
Scottish National Blood Transfusion Service Headquarters, Edinburgh, UK.
9
Scottish Center for Regenerative Medicine, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.
10
1] Kyoto Center for iPS Cell Research and Application, Kyoto University, Shogoin, Sakyo-ku, Kyoto, Japan. [2] International Society for Stem Cell Research at the time of submission and acceptance of this work.

Erratum in

  • Nat Biotechnol. 2014 Nov;32(11):1166. Cavanagro, Joy [corrected to Cavagnaro, Joy]; Feigel, Ellen [corrected to Feigal, Ellen].
PMID:
25093882
DOI:
10.1038/nbt.2973
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center